Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Gastric Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT07646574
What this trial is testing

Non-surgical Management After NIT for dMMR/MSI-H GC

Who this might be right for
Non-surgical Management;dMMR/MSI-H Gastric Cancer;Neoadjuvant Immunotherapy
Yong Zhou 12
Testing effectiveness (Phase 2)Study completedNCT04770623
What this trial is testing

Docetaxel and Irinotecan in Gastric Cancer

Who this might be right for
Stomach CancerGastric CancerChemotherapy Effect
Menoufia University 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07361991
What this trial is testing

IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer

Who this might be right for
Advan'ce'dAdvanced
The First Affiliated Hospital of Zhengzhou University 50
Testing effectiveness (Phase 2)Study completedNCT00976768
What this trial is testing

Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin

Who this might be right for
Advanced Gastric Cancer
Asan Medical Center 44
Testing effectiveness (Phase 2)Study completedNCT00394433
What this trial is testing

Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

Who this might be right for
Esophageal CancerStomach Cancer
Dana-Farber Cancer Institute 38
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Testing effectiveness (Phase 2)Study completedNCT03980925
What this trial is testing

Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.

Who this might be right for
Neuroendocrine TumorsNeuroendocrine NeoplasmGastroenteropancreatic Neuroendocrine Tumor
Grupo Espanol de Tumores Neuroendocrinos 37
Testing effectiveness (Phase 2)UnknownNCT03575637
What this trial is testing

Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University 180
Testing effectiveness (Phase 2)UnknownNCT05982834
What this trial is testing

Disitamab Vedotin, Fruquintinib and Tislelizumab in Second-line Treatment for HER2-positive MGC

Who this might be right for
HER2-positive Gastric CancerImmunotherapy
Fudan University 43
Testing effectiveness (Phase 2)UnknownNCT02924909
What this trial is testing

Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer

Who this might be right for
Esophageal CancerInduction Chemotherapy
Instituto Nacional de Cancer, Brazil 50
Testing effectiveness (Phase 2)Ended earlyNCT00064259
What this trial is testing

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00084617
What this trial is testing

Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+6 more
National Cancer Institute (NCI) 39
Early research (Phase 1)UnknownNCT00741676
What this trial is testing

Comparison of the Laparoscopy-Assisted Distal Gastrectomy and Open Distal Gastrectomy for Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasm
The Catholic University of Korea 124
Testing effectiveness (Phase 2)Study completedNCT00003055
What this trial is testing

Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03144843
What this trial is testing

Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.

Who this might be right for
Gastric Cancer
Sun Yat-sen University 110
Testing effectiveness (Phase 2)Study completedNCT02995850
What this trial is testing

A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric Cancer With Peritoneal Metastasis (PCI<12)
Yonsei University 25
Testing effectiveness (Phase 2)Study completedNCT00166881
What this trial is testing

Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin

Who this might be right for
Gastric Cancer
National Taiwan University Hospital 29
Testing effectiveness (Phase 2)Study completedNCT04923932
What this trial is testing

Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients

Who this might be right for
Gastric CancerEsophagogastric Junction Disorder
Hutchison Medipharma Limited 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT07143604
What this trial is testing

Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
AstraZeneca 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06339216
What this trial is testing

A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 30
Next Page